Meeting the unmet: from traditional to cutting‑edge techniques for poly lactide and poly lactide‑co‑glycolide microparticle manufacturing

다국어 초록 (Multilingual Abstract)

Background Polylactides (PLA) and poly lactide-co-glycolides (PLGA) undoubtedly are among the major drivers in the pharmaceutical market. Their relevance in pharmaceutics and biomedicine is well established in light of their sustainability, safety, tunable biodegradability, and versatility. However, polymer degradability and plasticity can somehow restrain industrial developability of PLA and PLGA formulations, especially in the form of microparticles (MP).
Area covered This review wants to deal with the known manufacturing issues of PLA/PLGA MP, debating the potential contribution of modern and cutting-edge manufacturing technologies to the solution of unmet production needs. Technological and regulatory aspects will be considered outlining the potential role of advanced manufacturing techniques in the advancement of PLA/PLGA MP production processes.
Expert opinion The multifaceted complexity of PLA/PLGA MP manufacturing processes demands adequate standardization and updated guidelines covering the so far unmet industrialization requirements. Novel and evolving manufacturing technologies will surely support the future development of bench-to-production plant transfer for such products. Careful evaluation of production costs is demanded in order to ensure process sustainability and patient’s outreach.

참고문헌 (Reference)

• 1 Albertini B, "β-cyclodextrin hinders PLGA plasticization during microparticle manufacturing" 30 : 375-383, 2015
• 2 D’Souza S, "enhanced degradation of lactide-co-glycolide polymer with basic nucleophilic drugs" 20 : 15-, 2015
• 3 Rawat A, "Validation of USP apparatus 4 method for microsphere in vitro release testing using risperdal consta" 420 : 198-205, 2011
• 4 Lee M, "Utilization of catalytic hydrolysis of ethyl acetate for solvent removal during microencapsulation" 30 : 346-355, 2013
• 5 FDA, "Two new intra-articular injections for knee osteoarthritis" 60 : 142-144, 2018
• 6 Huang X, "Tumor-targeted paclitaxelloaded folate conjugated poly(ethylene glycol)-poly(l-lactide)microparticles produced by supercritical fluid technology" 26 : 95-, 2015
• 7 FDA, "Triptorelin(Triptodur)for central precocious puberty" 60 : 7-8, 2018
• 8 Yaszemski MJ, "Tissue engineering and novel delivery systems" CRC Press 2003
• 9 Mutsatsa S, "The use of long-acting injectable antipsychotic medication" 6 : 114-117, 2017
• 10 Johnson OL, "The stabilization and encapsulation of human growth hormone into biodegradable microspheres" 14 : 730-735, 1997
• 11 Jain RA, "The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide)(PLGA)devices" 21 : 2475-2490, 2000
• 12 Giovagnoli S, "The influence of feedstock and process variables on the encapsulation of drug suspensions by spray-drying in fast drying regime : the case of novel antitubercular drug–palladium complex containing polymeric microparticles" 103 : 1255-1268, 2014
• 13 Nikolić N, "The impact of paliperidone palmitate long-acting injection on hospital admissions in a mental health setting" 32 : 95-102, 2017
• 14 Acharya G, "The hydrogel template method for fabrication of homogeneous nano/microparticles" 141 : 314-319, 2010
• 15 van de Weert M, "The effect of a water/organic solvent interface on the structural stability of lysozyme" 68 : 351-359, 2000
• 16 Al-Khattawi A, "The design and scale-up of spray dried particle delivery systems" 15 : 47-63, 2018
• 17 Shaver MP, "Tacticity control in the synthesis of poly(lactic acid)polymer stars with dipentaerythritol cores" 11 : 3673-3679, 2010
• 18 Guo W, "Sustained release donepezil loaded PLGA microspheres for injection : preparation, in vitro and in vivo study" 10 : 405-414, 2015
• 19 Casettari L, "Surface characterisation of bioadhesive PLGA/chitosan microparticles produced by supercritical fluid technology" 28 : 1668-1682, 2011
• 20 Tabernero A, "Supercritical fluids for pharmaceutical particle engineering : methods, basic fundamentals and modelling" 60 : 9-25, 2012
• 21 Kankala RK, "Supercritical fluid technology: an emphasis on drug delivery and related biomedical applications" 2017
• 22 Dhanda DS, "Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose" 168 : 239-250, 2013
• 23 Girotra P, "Supercritical fluid technology : a promising approach in pharmaceutical research" 18 : 22-38, 2013
• 24 Campardelli R, "Supercritical assisted injection in a liquid antisolvent for PLGA and PLA microparticle production" 287 : 12-19, 2016
• 25 Chen A-Z, "Study of lysozyme-polymer composite microparticles in supercritical CO2" 125 : 3175-3183, 2012
• 26 Kang Y-Q, "Study of lysozyme-loaded poly-l-lactide (PLLA) porous microparticles in a compressed CO2 antisolvent process" 6 : 3571-3583, 2013
• 27 Chen A-Z, "Study of Fe3O4–PLLA–PEG–PLLA magnetic microspheres based on supercritical CO2 : preparation, physicochemical characterization, and drug loading investigation" 67 : 139-148, 2012
• 28 Vladisavljević GT, "Structured microparticles with tailored properties produced by membrane emulsification" 225 : 53-87, 2015
• 29 Ramazani F, "Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres : state-of-the-art and challenges" 499 : 358-367, 2016
• 30 Bilati U, "Strategic approaches for overcoming peptide and protein instability within biodegradable nano-and microparticles" 59 : 375-388, 2005
• 31 ICH Q1A, "Stability testing of new drug substances and products. In: European Medicines Agency - Commission"
• 32 Ishwarya SP, "Sprayfreeze-drying : a novel process for the drying of foods and bioproducts" 41 : 161-181, 2015
• 33 Cheow WS, "Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery : effect of freeze-drying adjuvants" 404 : 289-300, 2011
• 34 Mundargi RC, "Spray drying technique to produce controlled release formulations of zidovudine—an anti-HIV drug" 122 : 2244-2251, 2011
• 35 Ziaee A, "Spray drying of pharmaceuticals and biopharmaceuticals : critical parameters and experimental process optimization approaches" 127 : 300-318, 2019
• 36 Cordeiro P, "Spray congealing : applications in the pharmaceutical industry" 31 : 69-72, 2013
• 37 Baxendale A, "Single shot tetanus vaccine manufactured by a supercritical fluid encapsulation technology" 413 : 147-154, 2011
• 38 Schoubben A, "Simple and scalable method for peptide inhalable powder production" 39 : 53-58, 2010
• 39 Keohane K, "Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles" 467 : 60-69, 2014
• 40 Tomic I, "Setting accelerated dissolution test for PLGA microspheres containing peptide, investigation of critical parameters affecting drug release rate and mechanism" 505 : 42-51, 2016
• 41 Zheng N, "Scientific and regulatory considerations for generic complex drug products containing nanomaterials" 19 : 619-631, 2017
• 42 "Salvacyl®, Moapar®. In: Debiopharm Group"
• 43 Ibrahim M, "SHetA2 dry powder aerosols for tuberculosis : formulation, design, and optimization using quality by design" 15 : 300-313, 2018
• 44 Fu H, "Risperidone-loaded longacting injectable microspheres prepared by ultra-fine particle processing system" 21 : 795-799, 2012
• 45 Gu X, "Review on SPG membrane emulsification : an efficient approach to prepare uniform microspheric drug carrier" 2 : 107-115, 2018
• 46 Zhou J, "Reverse engineering the 1-month Lupron Depot ®" 20 : 105-, 2018
• 47 Hu M, "Research advances of microencapsulation and its prospects in the petroleum industry" 2017
• 48 Lee Y-H, "Release profile characteristics of biodegradable-polymer-coated drug particles fabricated by dualcapillary electrospray" 145 : 58-65, 2010
• 49 Costantino HR, "Relationship between encapsulated drug particle size and initial release of recombinant human growth hormone from biodegradable microspheres" 93 : 2624-2634, 2004
• 50 Qi F, "Recent research and development of PLGA/PLA microspheres/nanoparticles: a review in scientific and industrial aspects" 2018
• 51 Ding D, "Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics" 92 : 1041-1060, 2018
• 52 Andhariya JV, "Recent advances in testing of microsphere drug delivery systems" 13 : 593-608, 2016
• 53 Liang Z, "Recent advances in controlled pulmonary drug delivery" 20 : 380-389, 2015
• 54 Koushik K, "Pulmonary delivery of deslorelin : large-porous PLGA particles and HPbetaCD complexes" 21 : 1119-1126, 2004
• 55 Werly EF, "Production of submicronic powder by spray-freezing" 9 : 567-571, 1964
• 56 Elvassore N, "Production of proteinloaded polymeric microcapsules by compressed CO2 in a mixed solvent" 40 : 795-800, 2001
• 57 Kluge J, "Production of PLGA microand nanocomposites by supercritical fluid extraction of emulsions : I. Encapsulation of lysozyme" 50 : 327-335, 2009
• 58 Kluge J, "Production of PLGA micro-and nanocomposites by supercritical fluid extraction of emulsions : II. Encapsulation of ketoprofen" 50 : 336-343, 2009
• 59 Lloyd DM, "Processing effects during rotating membrane emulsification" 466 : 8-17, 2014
• 60 Palmer D, "Printing particles : a highthroughput technique for the production of uniform, bioresorbable polymer microparticles and encapsulation of therapeutic peptides" 166 : 122-129, 2017
• 61 Wischke C, "Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles" 364 : 298-327, 2008
• 62 D’Souza S, "Preparation, characterization, and in vivo evaluation of olanzapine poly(d, l-lactide-co-glycolide) microspheres" 831381-, 2013
• 63 Chen F, "Preparation, characterization and in vitro release properties of morphine-loaded PLLAPEG-PLLA microparticles via solution enhanced dispersion by supercritical fluids" 24 : 1693-1705, 2013
• 64 Kang Y, "Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique" 70 : 85-97, 2008
• 65 Zhang Y-Z, "Preparation of water soluble drugs-loaded microparticles using modified solution enhanced dispersion by supercritical CO2" 221 : 343-350, 2012
• 66 Liu W, "Preparation of uniform-sized multiple emulsions and micro/nano particulates for drug delivery by membrane emulsification" 100 : 75-93, 2011
• 67 Liu R, "Preparation of uniform-sized PLA microcapsules by combining Shirasu porous glass membrane emulsification technique and multiple emulsion-solvent evaporation method" 103 : 31-43, 2005
• 68 Kondo K, "Preparation of sustained-release coated particles by novel microencapsulation method using three-fluid nozzle spray drying technique" 51 : 11-19, 2014
• 69 Xu Q, "Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery" 5 : 1575-1581, 2009
• 70 Koushik K, "Preparation of large porous deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process" 21 : 524-535, 2004
• 71 Giovagnoli S, "Preparation of large porous biodegradable microspheres by using a simple doubleemulsion method for capreomycin sulfate pulmonary delivery" 333 : 103-111, 2007
• 72 Liu R, "Preparation of insulin-loaded PLA/PLGA microcapsules by a novel membrane emulsification method and its release in vitro" 51 : 30-38, 2006
• 73 Kang Y, "Preparation of PLLA/PLGA microparticles using solution enhanced dispersion by supercritical fluids(SEDS)" 322 : 87-94, 2008
• 74 Zhao R, "Preparation and in vitro evaluation of biodegradable microspheres with narrow size distribution for pulmonary delivery" 79 : 930-938, 2018
• 75 Capan Y, "Preparation and characterization of poly(d, l-lactide-co-glycolide) microspheres for controlled release of human growth hormone" 4 : E28-, 2003
• 76 Gasparini G, "Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification" 61 : 199-207, 2008
• 77 Enlow EM, "Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings" 11 : 808-813, 2011
• 78 Oliveira MB, "Polymer-based microparticles in tissue engineering and regenerative medicine" 27 : 897-912, 2011
• 79 Burke PA, "Poly(lactide-coglycolide)microsphere formulations of darbepoetin alfa : spray drying is an alternative to encapsulation by spray-freeze drying" 21 : 500-506, 2004
• 80 Makadia HK, "Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier" 3 : 1377-1397, 2011
• 81 Perez A, "Poly (lactic-co-glycolic acid) particles prepared by microfluidics and conventional methods. Modulated particle size and rheology" 441 : 90-97, 2015
• 82 Wagenaar BW, "Piroxicam release from spray-dried biodegradable microspheres" 15 : 49-54, 1994
• 83 Giovagnoli S, "Physicochemical characterization and release mechanism of a novel prednisone biodegradable microsphere formulation" 97 : 303-317, 2008
• 84 Wanning S, "Pharmaceutical spray freeze drying" 488 : 136-153, 2015
• 85 Piacentini E, "Pharmaceutical particles design by membrane emulsification : preparation methods and applications in drug delivery" 23 : 302-318, 2017
• 86 Kaufman MB, "Pharmaceutical approval update" 42 : 733-755, 2017
• 87 Crowley MM, "Pharmaceutical applications of hot-melt extrusion : part I" 33 : 909-926, 2007
• 88 Allahyari M, "Peptide/protein vaccine delivery system based on PLGA particles" 12 : 806-828, 2016
• 89 Perry JL, "PRINT : a novel platform toward shape and size specific nanoparticle theranostics" 44 : 990-998, 2011
• 90 Leblanc D, "PLGA microspheres: the art of the science" Pharmaceutical Manufacturing 2018
• 91 Gavini E, "PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method : in vitro/in vivo studies" 57 : 207-212, 2004
• 92 Della Porta G, "PLGA microspheres by supercritical emulsion extraction : a study on insulin release in myoblast culture" 24 : 1831-1847, 2013
• 93 Kapoor DN, "PLGA : a unique polymer for drug delivery" 6 : 41-58, 2015
• 94 Lee BK, "PLA micro-and nano-particles" 107 : 176-191, 2016
• 95 "Orbis biosciences precision particle fabrication technology. In: Orbis biosciences"
• 96 Lu J, "Optimization and evaluation of monodispersed tetrandrine-loaded PLA microspheres prepared with a SPG membrane emulsification technique" 4 : 1-11, 2017
• 97 Wan F, "One-step production of protein-loaded PLGA microparticles via spray drying using 3-fluid nozzle" 31 : 1967-1977, 2014
• 98 Liu W, "On the spray drying of uniform functional microparticles" 22 : 1-12, 2015
• 99 Cricchio V, "Novel superparamagnetic microdevices based on magnetized PLGA/PLA microparticles obtained by supercritical fluid emulsion and coating by carboxybetaine-functionalized chitosan allowing the tuneable release of therapeutics" 106 : 2097-2105, 2017
• 100 Schoubben A, "Novel composite microparticles for protein stabilization and delivery" 36 : 226-234, 2009
• 101 "New FDA Approved Drugs for 2019 | CenterWatch"
• 102 Kale TR, "Needle free injection technology—an overview" 5 : 148-, 2014
• 103 Yandrapu SK, "Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumab" 10 : 4676-4686, 2013
• 104 Della Porta G, "NSAID drugs release from injectable microspheres produced by supercritical fluid emulsion extraction" 99 : 1484-1499, 2010
• 105 Böhmer MR, "Monodisperse polymeric particles prepared by ink-jet printing : double emulsions, hydrogels and polymer mixtures" 79 : 47-52, 2010
• 106 Dutta S, "Modern frontiers and applications of spray-freeze-drying in design of food and biological supplements" 41 : e12881-, 2018
• 107 Gupta V, "Microsphere-based scaffolds in regenerative engineering" 19 : 135-161, 2017
• 108 Rosca ID, "Microparticle formation and its mechanism in single and double emulsion solvent evaporation" 99 : 271-280, 2004
• 109 Tu LS, "Micronisation and microencapsulation of pharmaceuticals using a carbon dioxide antisolvent" 126 : 134-149, 2002
• 110 Duncanson WJ, "Microfluidic synthesis of advanced microparticles for encapsulation and controlled release" 12 : 2135-2145, 2012
• 111 Youan B-BC, "Microencapsulation of superoxide dismutase into biodegradable microparticles by spray-drying" 11 : 209-214, 2004
• 112 Chen A-Z, "Microencapsulation of puerarin nanoparticles by poly(l-lactide)in a supercritical CO2 process" 5 : 2913-2919, 2009
• 113 Mishima K, "Microencapsulation of proteins by rapid expansion of supercritical solution with a nonsolvent" 46 : 857-865, 2000
• 114 Ma G, "Microencapsulation of protein drugs for drug delivery : strategy, preparation, and applications" 193 : 324-340, 2014
• 115 Kim J-H, "Microencapsulation of naproxen using rapid expansion of supercritical solutions" 12 : 650-661, 1996
• 116 Yeo Y, "Microencapsulation methods for delivery of protein drugs" 6 : 213-230, 2001
• 117 Soh SH, "Microencapsulation and nanoencapsulation using supercritical fluid(SCF)techniques" 11 : 21-, 2019
• 118 Piacentini E, "Membrane emulsification technology : twenty-five years of inventions and research through patent survey" 468 : 410-422, 2014
• 119 Silva PS, "Membrane emulsification : formation of water in oil emulsions using a hydrophilic membrane" 532 : 297-304, 2017
• 120 Qi F, "Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification" 10 : 4247-4256, 2014
• 121 Berkland C, "Macromolecule release from monodisperse PLG microspheres : control of release rates and investigation of release mechanism" 96 : 1176-1191, 2007
• 122 Tran M-K, "Lysozyme encapsulation within PLGA and CaCO3 microparticles using supercritical CO2 medium" 79 : 159-169, 2013
• 123 Giovagnoli S, "Long-term delivery of superoxide dismutase and catalase entrapped in poly(lactideco-glycolide)microspheres : in vitro effects on isolated neonatal porcine pancreatic cell clusters" 107 : 65-77, 2005
• 124 Ricci M, "Ketoprofen controlled release from composite microcapsules for cell encapsulation : effect on post-transplant acute inflammation" 107 : 395-407, 2005
• 125 Nykamp G, "Jet milling–a new technique for microparticle preparation" 242 : 79-86, 2002
• 126 Ye M, "Issues in long-term protein delivery using biodegradable microparticles" 146 : 241-260, 2010
• 127 Patel R, "Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?" 48 : 1616-1623, 2018
• 128 Yamaguchi Y, "Insulin-loaded biodegradable PLGA microcapsules : initial burst release controlled by hydrophilic additives" 81 : 235-249, 2002
• 129 Campardelli R, "Instantaneous coprecipitation of polymer/drug microparticles using the supercritical assisted injection in a liquid antisolvent" 120 : 151-160, 2017
• 130 Guo Y, "Injectable sustained-release depots of PLGA microspheres for insoluble drugs prepared by hot-melt extrusion" 34 : 2211-2222, 2017
• 131 Das S, "Inhaled dry powder formulations for treating tuberculosis" 12 : 26-39, 2015
• 132 O’Connor G, "Inhalable poly(lactic-co-glycolic acid)(PLGA)microparticles encapsulating all-trans-retinoic acid(ATRA)as a host-directed, adjunctive treatment for mycobacterium tuberculosis infection" 134 : 153-165, 2019
• 133 Liu R, "Influence of process parameters on the size distribution of PLA microcapsules prepared by combining membrane emulsification technique and double emulsion-solvent evaporation method" 45 : 144-153, 2005
• 134 Vladisavljević GT, "Industrial labon-a-chip : design, applications and scale-up for drug discovery and delivery" 65 : 1626-1663, 2013
• 135 D’Souza S, "In vitro–in vivo correlation from lactide-co-glycolide polymeric dosage forms" 3 : 131-142, 2014
• 136 Luan X, "In situ forming microparticle system for controlled delivery of leuprolide acetate : influence of the formulation and processing parameters" 27 : 143-149, 2006
• 137 D’Souza S, "IVIVC from long acting olanzapine microspheres" 2014
• 138 Acharya G, "Hydrogel templates for the fabrication of homogeneous polymer microparticles" 726 : 179-185, 2011
• 139 Lang B, "Hot-melt extrusion–basic principles and pharmaceutical applications" 40 : 1133-1155, 2014
• 140 Liang Y-J, "High-performance poly(lactic-coglycolic acid)-magnetic microspheres prepared by rotating membrane emulsification for transcatheter arterial embolization and magnetic ablation in VX2 liver tumors" 9 : 43478-43489, 2017
• 141 EMA, "Guideline on the pharmacokinetic and clinical evaluation 4 of modified release dosage forms"
• 142 Baker GL, "Glass transitions in polylactides" 48 : 64-84, 2008
• 143 Chen A-Z, "Generation of porous poly-l-lactide microspheres by emulsion-combined precipitation with a compressed CO2 antisolvent process" 1 : 2967-2975, 2013
• 144 Han FY, "Formulation of bioerodible ketamine microparticles as an analgesic adjuvant treatment produced by supercritical fluid polymer encapsulation" 10 : 264-, 2018
• 145 Chen A-Z, "Formation of methotrexate-PLLA-PEG-PLLA composite microspheres by microencapsulation through a process of suspension-enhanced dispersion by supercritical CO2" 7 : 3013-3022, 2012
• 146 Patomchaiviwat V, "Formation of inhalable rifampicin-poly(l-lactide)microparticles by supercritical anti-solvent process" 9 : 1119-1129, 2008
• 147 Rivera PA, "Fluconazole encapsulation in PLGA microspheres by spray-drying" 21 : 203-211, 2004
• 148 Martín-Banderas L, "Flow focusing : a versatile technology to produce size-controlled and specific-morphology microparticles" 1 : 688-692, 2005
• 149 Mu L, "Fabrication, characterization and in vitro release of paclitaxel(Taxol)loaded poly(lactic-co-glycolic acid)microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers" 76 : 239-254, 2001
• 150 Guan J, "Fabrication of polymeric microparticles for drug delivery by soft lithography" 27 : 4034-4041, 2006
• 151 Lee BK, "Fabrication of drug-loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system" 427 : 305-310, 2012
• 152 Berkland C, "Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions" 73 : 59-74, 2001
• 153 Wang Y, "FDA’s regulatory science program for generic PLA/PLGA-based drug products" 2016
• 154 FDA, "FDA guidance for industry: technical considerations for pen, jet, and related injectors intended for use with drugs and biological products - ECA Academy"
• 155 Miranda MS, "Exploring inhalable polymeric dry powders for anti-tuberculosis drug delivery" 93 : 1090-1103, 2018
• 156 Ungaro F, "Engineered PLGA nanoand micro-carriers for pulmonary delivery : challenges and promises" 64 : 1217-1235, 2012
• 157 Lu Y, "Encyclopedia of pharmaceutical science and technology" Informa Healthcare 2012
• 158 Vladisavljević GT, "Encyclopedia of membranes" Springer 1228-1231, 2016
• 159 Avgoustakis K, "Encyclopedia of biomedical polymers and polymeric biomaterials, 11 volume set" Taylor & Francis Group 2015
• 160 Campardelli R, "Encapsulation of titanium dioxide nanoparticles in PLA microspheres using supercritical emulsion extraction to produce bactericidal nanocomposites" 15 : 1987-, 2013
• 161 Xie J, "Encapsulation of proteins in biodegradable polymeric microparticles using electrospray in the Taylor cone-jet mode" 97 : 1278-1290, 2007
• 162 Xie J, "Encapsulation of protein drugs in biodegradable microparticles by co-axial electrospray" 317 : 469-476, 2008
• 163 Young TJ, "Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent" 88 : 640-650, 1999
• 164 Vladisavljević GT, "Emulsion templating of poly(lactic acid)particles : droplet formation behavior" 28 : 12948-12954, 2012
• 165 Xie J, "Electric field controlled electrospray deposition for precise particle pattern and cell pattern formation" 56 : 2607-2621, 2010
• 166 Allison SD, "Effect of structural relaxation on the preparation and drug release behavior of poly(lactic-co-glycolic)acid microparticle drug delivery systems" 97 : 2022-2035, 2008
• 167 Schoubben A, "Effect of agitation regimen on the in vitro release of leuprolide from poly(lactic-co-glycolic)acid microparticles" 101 : 1212-1220, 2012
• 168 Mao S, "Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres" 334 : 137-148, 2007
• 169 Schoubben A, "Dynamic behavior of a spring-powered micronozzle needle-free injector" 491 : 91-98, 2015
• 170 Thomasin C, "Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation" 87 : 269-275, 1998
• 171 Chattopadhyay P, "Drug encapsulation using supercritical fluid extraction of emulsions" 95 : 667-679, 2006
• 172 Hickey AJ, "Drug delivery systems for tuberculosis prevention and treatment" Wiley 2016
• 173 Panzitta M, "Drug delivery system innovation and health technology assessment : upgrading from clinical to technological assessment" 495 : 1005-1018, 2015
• 174 Briken P, "Double-blind, controlled, clinical trial planned in germany to investigate the efficacy of psychotherapy combined with triptorelin in adult male patients with severe pedophilic disorders : presentation of the study protocol" 49 : 306-313, 2012
• 175 Nagavarma BVN, "Different techniques for preparation of polymeric nanoparticles-A" 5 : 16-23, 2012
• 176 Kanojia G, "Developments in the formulation and delivery of spray dried vaccines" 13 : 2364-2378, 2017
• 177 D’Souza S, "Development of risperidone PLGA microspheres" 2014 : 620464-, 2014
• 178 Cleland JL, "Development of poly-(d, l-lactide–coglycolide)microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis" 72 : 13-24, 2001
• 179 Puccetti M, "Development of novel indole-3-aldehyde-loaded gastro-resistant spray-dried microparticles for postbiotic small intestine local delivery" 107 : 2341-2353, 2018
• 180 Chen A-Z, "Development of core-shell microcapsules by a novel supercritical CO2 process" 20 : 751-758, 2009
• 181 Palazzo F, "Development of a spray-drying method for the formulation of respirable microparticles containing ofloxacin-palladium complex" 440 : 273-282, 2013
• 182 Tavares M, "Development of PLGA dry powder microparticles by supercritical CO2-assisted spray-drying for potential vaccine delivery to the lungs" 128 : 235-243, 2017
• 183 Chen A-Z, "Development of Fe3O4-poly(l-lactide)magnetic microparticles in supercritical CO2" 330 : 317-322, 2009
• 184 Tracy MA, "Development and scale-up of a microsphere protein delivery system" 14 : 108-115, 1998
• 185 Wan F, "Design of PLGA-based depot delivery systems for biopharmaceuticals prepared by spray drying" 498 : 82-95, 2016
• 186 Peng X, "Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia" 3 : 9-14, 2011
• 187 Swider E, "Customizing poly(lactic-coglycoli acid)particles for biomedical applications" 73 : 38-51, 2018
• 188 Barolet D, "Current trends in needle-free jet injection : an update" 11 : 231-238, 2018
• 189 Vo CL-N, "Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs" 85 : 799-813, 2013
• 190 Ho TH, "Cross-flow membrane emulsification technique for fabrication of drug-loaded particles" 4 : 045008-, 2013
• 191 Di Giorgio L, "Costs of administering injectable contraceptives through health workers and selfinjection : evidence from Burkina Faso, Uganda, and Senegal" 98 : 389-395, 2018
• 192 Yang L, "Cost-effectiveness of long-acting risperidone injection versus alternative atypical antipsychotic agents in patients with schizophrenia in China" 12 (12): S66-S69, 2009
• 193 Ravasio R, "Cost-effectiveness analysis of paliperidone palmitate versus long-acting risperidone as maintenance treatment in schizophrenia patients in Italy" 2015
• 194 Berkland C, "Controlling surface nano-structure using flow-limited field-injection electrostatic spraying(FFESS)of poly(d, l-lactide-co-glycolide)" 25 : 5649-5658, 2004
• 195 Falk R, "Controlled release of ionic compounds from poly(l-lactide)microspheres produced by precipitation with a compressed antisolvent" 44 : 77-85, 1997
• 196 Lee S, "Controlled delivery of a hydrophilic drug from a biodegradable microsphere system by supercritical anti-solvent precipitation technique" 23 : 741-749, 2006
• 197 Li W, "Controllable microfluidic fabrication of Janus and microcapsule particles for drug delivery applications" 5 : 23181-23188, 2015
• 198 Falco N, "Continuous supercritical emulsions extraction : packed tower characterization and application to poly(lactic-co-glycolic acid)+ insulin microspheres production" 51 : 8616-8623, 2012
• 199 Della Porta G, "Continuous supercritical emulsions extraction : a new technology for biopolymer microparticles production" 108 : 676-686, 2011
• 200 Hancocks RD, "Comparisons between membranes for use in cross flow membrane emulsification" 116 : 382-389, 2013
• 201 Jain RA, "Comparison of various injectable protein-loaded biodegradable poly(lactide-co-glycolide)(PLGA)devices : in situ-formed implant versus in situformed microspheres versus isolated microspheres" 5 : 201-207, 2000
• 202 Guo L, "Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients" 96 : e5482-, 2017
• 203 Ayyagari R, "Comparing the cost of treatment with octreotide long-acting release versus lanreotide in patients with metastatic gastrointestinal neuroendocrine tumors" 10 : 408-415, 2017
• 204 Zhu C, "Comparative studies on exenatide-loaded poly(d, l-lactic-co-glycolic acid)microparticles prepared by a novel ultra-fine particle processing system and spray drying" 132 : 103-110, 2015
• 205 Mueller M, "Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice" 162 : 159-166, 2012
• 206 Zhang L, "Coaxial electrospray of ranibizumab-loaded microparticles for sustained release of anti-VEGF therapies" 10 : e0135608-, 2015
• 207 Campardelli R, "Biopolymer particles for proteins and peptides sustained release produced by supercritical emulsion extraction" 42 : 239-246, 2012
• 208 Han FY, "Bioerodable PLGA-based microparticles for producing sustained-release drug formulations and strategies for improving drug loading" 7 : 185-, 2016
• 209 Anderson JM, "Biodegradation and biocompatibility of PLA and PLGA microspheres" 64 : 72-82, 2012
• 210 Giovagnoli S, "Biodegradable microspheres as carriers for native superoxide dismutase and catalase delivery" 5 : 1-9, 2004
• 211 Casagrande S, "Biodegradable composite porous poly(dl-lactide-co-glycolide) scaffold supports mesenchymal stem cell differentiation and calcium phosphate deposition" 2017
• 212 Royals MA, "Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys" 45 : 231-239, 1999
• 213 Giovagnoli S, "Bioactive long-term release from biodegradable microspheres preserves implanted ALGPLO-ALG microcapsules from in vivo response to purified alginate" 27 : 285-295, 2010
• 214 Garner J, "Beyond Q1/Q2 : the impact of manufacturing conditions and test methods on drug release from PLGA-based microparticle depot formulations" 107 : 353-361, 2018
• 215 Claussen IC, "Atmospheric freeze drying—a review" 25 : 947-957, 2007
• 216 Kim J, "Ammonolysis-induced solvent removal : a facile approach for solidifying emulsion droplets into PLGA microspheres" 8 : 3900-3907, 2007
• 217 Im H-Y, "Ammonolysis-based microencapsulation technique using isopropyl formate as dispersed solvent" 382 : 130-138, 2009
• 218 Sosnik A, "Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers" 223 : 40-54, 2015
• 219 Selmin F, "Accelerated polymer biodegradation of risperidone poly(d, l-lactide-co-glycolide)microspheres" 13 : 1465-1472, 2012
• 220 Go DP, "A simple, scalable process for the production of porous polymer microspheres by ink-jetting combined with thermally induced phase separation" 31 : 685-698, 2014
• 221 González GP, "A review of clinical and economic evaluations applied to psychotropic therapies used in the treatment of schizophrenia in Argentina" 2 : 233-239, 2018
• 222 Benvenutti DF, "A novel stabilizing approach to improve the manufacturing of biodegradable microparticles entrapping plasticizing active molecules: the case of 4-methoxychalcone" 2018
• 223 Adami R, "A new supercritical assisted atomization configuration, for the micronization of thermolabile compounds" 173 : 55-61, 2011
• 224 Wichert B, "A new method for the preparation of drug containing polylactic acid microparticles without using organic solvents" 14 : 269-283, 1990
• 225 Ghaderi R, "A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles using supercritical fluids" 10 : 1-9, 2000
• 226 Silverman BL, "A long-acting human growth hormone (Nutropin Depot): efficacy and safety following two years of treatment in children with growth hormone deficiency" 15 (15): 715-722, 2002
• 227 Greystone Research Associates, "A comprehensive report sustained release injectables to 2024" Greystone Research Associates 2018
• 228 Wang Y, "A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles" 424 : 98-106, 2012
• 229 Tice T, "A 30-year history of PLG applications in parenteral controlled drug release" 41 : 26-32, 2017
• 230 Sastre RL, "5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(d, l-lactide)and poly(d, l-lactide-co-glycolide)polymers" 338 : 180-190, 2007